Skip to content
Areas of Research
- Role of earlier, subclinical atherosclerosis (hardening of the arteries) as assessed by coronary calcification and other modalities
- Role of metabolic syndrome / cardio-kidney metabolic syndrome in the development of cardiovascular disease
- Role of hypertensive subtypes such as isolated systolic hypertension in cardiovascular disease risk
- Epidemiology and management of dyslipidemia, especially LDL-cholesterol, lipoprotein(a), and hypertriglyceridemia
- Clinical trials on newer and novel therapies for managing dyslipidemia, including lipoprotein(a)
- Leveraging of real-world electronic medical record databases to examine dyslipidemia, diabetes, and cardiovascular disease quality of care issues